Máj- és epeúti rák: vizsgálatok itt: Szerbia

4 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

  Where

  Belgrade, Kamenitz

  Életkor

  18 év and over

  People

  286 worldwide

  Run by

  Jazz Pharmaceuticals

  See details and how to joinNCT06282575 · EU 2023-508219-21-00
• No phaseNot yet taking people in Szerbia
  Validation of Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma

  Where

  Belgrade

  Életkor

  18 év and over

  People

  60

  Run by

  University of Belgrade

  See details and how to joinNCT07414433
• No phaseTaking people
  Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma

  Where

  Belgrade

  Életkor

  18 év and over

  People

  15

  Run by

  University of Belgrade

  See details and how to joinNCT07378709
• 3. fázisTaking people
  Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

  Where

  Belgrade, Kamenitz, Kladovo, Kragujevac

  Életkor

  18 év and over

  People

  471 worldwide

  Run by

  Can-Fite BioPharma

  See details and how to joinNCT05201404